---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-110484"
form_type: "8-K"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2025-08-20T23:59:59+00:00"
generated_at: "2026-05-17T11:04:16.627106+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Alaunos regains Nasdaq compliance after reporting $3.66M equity in Q2 2025

## Summary
- Nasdaq notified Alaunos of compliance on August 19, 2025, following prior stockholders' equity deficiency.
- Company had reported $2.06M equity in 2024 10-K, below $2.5M minimum for continued listing.
- Q2 2025 10-Q showed $3.66M equity, meeting Nasdaq's requirement; compliance plan submitted earlier.
- Matter closed; no immediate delisting risk.

## SEC filing metadata
- accession: 0000950170-25-110484
- form_type: 8-K
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2025-08-20T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000095017025110484/0000950170-25-110484-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000095017025110484/tcrt-20250819.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-110484
- JSON: https://secwatch.observer/filing/0000950170-25-110484.json
- Plain text: https://secwatch.observer/filing/0000950170-25-110484.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.